内皮细胞核心生物钟基因bmal1在血压稳态调控中的作用和机制研究
批准号:
32071157
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
陈丽红
依托单位:
学科分类:
衰老与生物节律
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
陈丽红
中文摘要
生物钟对维持血压的生理稳态至关重要。我们前期利用可诱导的核心生物钟基因bmal1全身敲除小鼠证实基础血压的昼夜节律主要受控于生物钟而非行为,但bmal1参与血压调控的细胞基础和分子机制,及其在高血压发生发展中的作用尚不明确。内皮细胞与血压调节密切相关,我们推测内皮细胞bmal1在维持正常血压及其昼夜节律中发挥重要作用。预实验发现敲除内皮细胞bmal1使小鼠血压下降、节律减弱,且AngII的升压效应被抑制;内皮细胞过表达bmal1可抑制血管舒张因子PGI2的分泌及其合酶PGIS的转录;提示敲除内皮细胞bmal1可减缓高血压,其机制可能与PGIS/PGI2通路的活化有关。本课题将利用内皮细胞组织特异性bmal1基因敲除或转基因小鼠,结合离体血管环和体外细胞实验,深入探讨内皮细胞bmal1在基础血压稳态维持及高血压发生发展中的作用和机制,为明晰生物钟在血压调控中的作用,及高血压的防治提供新思路。
英文摘要
The circadian clock is essential for the maintenance of blood pressure (BP) homeostasis. By using the inducible bmal1 global knockout mice, we recently reported that the circadian rhythm of BP is controlled by the biological clock rather than the behavior. However, the cellular and molecular mechanisms of bmal1 in BP homeostasis regulation remain unclear, and the role of bmal1 in hypertension has not been investigated yet. Vascular endothelial cells are essential for BP homeostasis. By generating a mouse line with bmal1 selectively deficient in endothelial cells (ECs) and performing preliminary experiments, we found that selective deletion of bmal1 in ECs significantly lowers basal BP and decreases its day-night variation in mice. In addition, the acute vasopressor response of AngII was also blunted when bmal1 is knockout in ECs. Therefore, we speculate that EC bmal1 is fundamental in maintaining normal BP levels and its circadian rhythm, deletion bmal1 in ECs might prevent against hypertension. Furthermore, we found that overexpression of bmal1 reduces the secretion of PGI2, an endothelium-derived vessel dilator, and inhibits the expression of PGI2 synthase (PGIS) in cultured ECs, suggesting that the BP lowering effect of EC bmal1 deletion might be attributable to the activation of endothelial PGIS/PGI2 pathway. To further verify our hypothesis, we will use two mouse lines with bmal1 either conditionally deleted or selectively overexpressed in ECs to deeply investigate the role of EC bmal1 in BP homeostasis. Mesenteric artery vascular rings and in vitro cell culture experiments will be extensively performed for exploring the underlying mechanisms. This study may provide important theoretical basis for elucidating the role of circadian clock on BP homeostasis regulation and provide new targets for the prevention and treatment of hypertension.
生物钟是调控生命活动周期性变化的核心机制,其中血压的昼夜节律波动是其典型表征之一。作为生物钟调控网络的核心转录因子,bmal1在心血管系统中的功能尚未完全阐明。本研究聚焦于血管内皮细胞bmal1在血压稳态调节中的作用和机制研究。我们通过Cre-LoxP系统构建内皮细胞特异性bmal1敲除(EC-bmal1 KO)及其同窝对照野生型小鼠(EC-bmal1 WT)发现,无论在日间静息状态还是夜间活动状态,EC-bmal1 KO小鼠的基础血压都显著低于EC-bmal1 WT小鼠,但对血压昼夜节律振荡影响有限。两组小鼠分别给予高盐饮食及或通过血管紧张素II(AngII)静脉注射或皮下缓释泵包埋诱导高血压发现,无论是急性大剂量静脉注射还是慢性持续灌注AngII,EC-bmal1 KO小鼠的收缩压增加幅度均显著低于WT小鼠。体外血管环实验显示KO小鼠的肠系膜动脉对AngII的反应性明显降低,且高血压状态下的血管舒张功能障碍状态较WT组显著改善,提示内皮细胞bmal1参与了AngII收缩血管及导致血管舒张功能障碍的作用,选择性敲除内皮细胞bmal1可抵抗AngII诱导的血管收缩,改善血管舒张功能障碍,进而抵抗高血压的发生发展。机制研究表明,KO小鼠血清及尿液中血管舒张因子前列环素(PGI2)的分泌水平明显高于EC-bmal1 WT小鼠。分子生物学实验证实,内皮细胞过表达bmal1可显著抑制前列环素合成酶(PGIS)的基因表达、减少PGI2分泌,提示敲除内皮细胞bmal1可能是通过增加PGIS的表达,促进PGI2分泌,进而促进血管舒张和血压下降。最后,我们通过药理学方法阻断PGIS/PGI2/IP信号通路进一步确认PGI2在内皮细胞bmal1参与血压稳态调控中的关键作用,发现IP受体抑制剂Cay10441或PGI2生物合成抑制剂吲哚美辛可完全阻断两组血管/小鼠对AngII诱导的血管收缩、内皮舒张障碍和升压反应的差异。我们得出结论:内皮细胞特异性敲除bmal1基因可降低小鼠基础血压,并缓解AngII 诱导的血压升高。PGIS作为BMAL1 的靶基因,参与了内皮细胞bmal1 对血压的稳态调控;敲除内皮细胞bmal1 可通过增加PGIS的表达,促进PGI2分泌,进而促进血管舒张、血压下降。内皮细胞bmal1在正常血压的稳态维持和高血压的发生发展中均发挥重要作用。
巨噬细胞COX-2/mPGES-1/PGE2/EP4通路在急性心肌梗死中的作用
-
批准号:81670242
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2016
-
负责人:陈丽红
-
依托单位:
国内基金
海外基金